US Patent 7329675 Substituted azabicyclic compounds
Patent 7329675 was granted and assigned to Aventis Pharma on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+12 properties)
Infobox
Patent Inventor Names
Christopher Hulme0
Daniel Gerard McGarry0
David John Aldous0
Fu-Chih Huang0
Gregory Bernard Poli0
John Robinson Regan0
Kevin Joseph Moriarty0
Paul Joseph Cox0
Peter Charles Astles0
Rose Mappilakunnel Mathew0
Shelley Bower0
Stevan Wakefield Djuric0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+92 characters)
Article
Patent abstract
This invention is directed to physiologically active compounds of formula (I)
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07329675 Substituted azabicyclic compounds US Patent 7329675 Substituted azabicyclic compounds
Infobox
Patent Number
073296750
Patent Number
73296750
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073296750
Date of Patent
February 12, 2008
0Patent Application Number
109330770
Date Filed
September 1, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07329675 Substituted azabicyclic compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07329675
Date of patent
February 12, 2008
Patent application number
10933077
Date Filed
September 1, 2004
Patent primary examiner
Find more entities like US Patent 7329675 Substituted azabicyclic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
